Puma Biotechnology, Inc. Profile Avatar - Palmy Investing

Puma Biotechnology, Inc.

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the pati…

Biotechnology
US, Los Angeles [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of PBYI's Analysis
CIK: 1401667 CUSIP: 74587V107 ISIN: US74587V1070 LEI: - UEI: -
Secondary Listings
PBYI has no secondary listings inside our databases.